First, we identified that Pomc and α-MSH expression in the heart is modulated by experimental pressure overload and showed that pharmacological treatment with α-MSH analog protects against pathological cardiac hypertrophy and LV systolic dysfunction. The gene discussed is POMC; the disease is cardiac hypertrophy.